Boehringer Ingelheim has licensed global rights, excluding Greater China, to SIM0709 from Simcere in a deal tied to up...

Nurix Therapeutics has initiated Daybreak, a pivotal, single‑arm phase 2 study of its oral BTK degrader bexobrutideg in relapsed/refractory...

PDS Biotechnology reported early clinical data from an NCI-led study showing its investigational tumor-targeted IL-12 immunocytokine, PDS01ADC, combined with...

Mabtech and Sai Life Sciences have formed a collaboration that designates Sai’s Boston site as a co-marketed U.S. execution...

Sanofi closed 2025 with a sharp acceleration in Q4 performance and set a higher bar for 2026. Fourth-quarter sales...

Roche posted a 7% increase in 2025 Group sales at constant exchange rates, with Pharmaceuticals up 9% and Diagnostics...

Roche posted a stronger-than-expected 2025 finish, with group sales up 7% at constant exchange rates to CHF 61.5 billion,...

Leios Therapeutics has licensed regional rights to 10XB-101, its minimally invasive injectable for focal fat reduction and body contouring,...

Enlivex Therapeutics has listed its primary treasury asset, the RAIN token, on WhiteBIT, effective January 21, 2026. WhiteBIT, the...

Adagene reported unaudited year-end cash of $74.5 million, guiding runway into late 2027, and outlined a dense slate of...